{"id":"https://openalex.org/W2910094802","doi":"https://doi.org/10.1158/1078-0432.ccr-18-2243","title":"Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non\u2013small Cell Lung Cancer Patients","display_name":"Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non\u2013small Cell Lung Cancer Patients","alternate_titles":[],"publication_year":2019,"publication_date":"2019-04-01","ids":{"openalex":"https://openalex.org/W2910094802","doi":"https://doi.org/10.1158/1078-0432.ccr-18-2243","mag":"2910094802","pmid":"https://pubmed.ncbi.nlm.nih.gov/30642911"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-18-2243","doi":"https://doi.org/10.1158/1078-0432.ccr-18-2243","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-18-2243","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2910094802"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pure.rug.nl/ws/files/1045639733/2219.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031007260","display_name":"Pauline L. de Goeje","orcid":"https://orcid.org/0000-0001-5680-4495","observed_orcids":["https://orcid.org/0000-0001-5680-4495"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pauline L. de Goeje","raw_affiliation_strings":["1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands","2Erasmus MC Cancer Institute, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"2Erasmus MC Cancer Institute, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063631436","display_name":"Myrthe Poncin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Myrthe Poncin","raw_affiliation_strings":["1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands","2Erasmus MC Cancer Institute, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"2Erasmus MC Cancer Institute, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004228936","display_name":"Koen Bezemer","orcid":"https://orcid.org/0009-0007-3452-6771","observed_orcids":["https://orcid.org/0009-0007-3452-6771"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Koen Bezemer","raw_affiliation_strings":["1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands","2Erasmus MC Cancer Institute, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"2Erasmus MC Cancer Institute, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080628121","display_name":"Margaretha E.H. Kaijen-Lambers","orcid":"https://orcid.org/0009-0007-8371-7240","observed_orcids":["https://orcid.org/0009-0007-8371-7240"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Margaretha E.H. Kaijen-Lambers","raw_affiliation_strings":["1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands","2Erasmus MC Cancer Institute, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"2Erasmus MC Cancer Institute, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065110382","display_name":"Harry J.M. Groen","orcid":"https://orcid.org/0000-0002-2978-5265","observed_orcids":["https://orcid.org/0000-0002-2978-5265"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Harry J.M. Groen","raw_affiliation_strings":["3Groningen University Medical Center, Department of Respiratory Disease, Groningen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Groningen University Medical Center, Department of Respiratory Disease, Groningen, the Netherlands","institution_ids":["https://openalex.org/I1334415907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016904876","display_name":"Egbert Frederik Smit","orcid":"https://orcid.org/0000-0002-7329-6995","observed_orcids":["https://orcid.org/0000-0002-7329-6995"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Egbert F. Smit","raw_affiliation_strings":["4Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016567527","display_name":"Anne\u2010Marie C. Dingemans","orcid":"https://orcid.org/0000-0001-6105-182X","observed_orcids":["https://orcid.org/0000-0001-6105-182X","https://orcid.org/0000-0002-7069-6598"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anne-Marie C. Dingemans","raw_affiliation_strings":["5Department of Respiratory Disease, Maastricht University Medical Center, Maastricht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Respiratory Disease, Maastricht University Medical Center, Maastricht, the Netherlands","institution_ids":["https://openalex.org/I2800191616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028232727","display_name":"Andr\u00e9 Kunert","orcid":"https://orcid.org/0000-0003-0253-8982","observed_orcids":["https://orcid.org/0000-0003-0253-8982"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andr\u00e9 Kunert","raw_affiliation_strings":["1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands","2Erasmus MC Cancer Institute, Rotterdam, the Netherlands","6Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"2Erasmus MC Cancer Institute, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]},{"raw_affiliation_string":"6Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051066209","display_name":"Rudi W. Hendriks","orcid":"https://orcid.org/0000-0003-2291-0382","observed_orcids":["https://orcid.org/0000-0003-2291-0382"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rudi W. Hendriks","raw_affiliation_strings":["1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012937808","display_name":"Joachim G.J.V. Aerts","orcid":"https://orcid.org/0000-0001-6662-2951","observed_orcids":["https://orcid.org/0000-0001-6662-2951"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joachim G.J.V. Aerts","raw_affiliation_strings":["1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands","2Erasmus MC Cancer Institute, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pulmonary Medicine, Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"2Erasmus MC Cancer Institute, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3669,"has_fulltext":true,"cited_by_count":47,"citation_normalized_percentile":{"value":0.90344114,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"25","issue":"7","first_page":"2219","last_page":"2227"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9879999756813049},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9860000014305115},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/cd8-t-cell-expansion","display_name":"CD8+ T cell proliferation","score":0.8889999985694885},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5920000076293945},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.9850000143051147},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":1.0},{"id":"https://openalex.org/keywords/co-inhibitory-receptors","display_name":"co-inhibitory receptors","score":0.8199999928474426},{"id":"https://openalex.org/keywords/nitroglycerin-patch","display_name":"nitroglycerin patch","score":0.7749999761581421},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.36899998784065247},{"id":"https://openalex.org/keywords/t-cell-subsets","display_name":"T cell subsets","score":0.5059999823570251},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.6399999856948853},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6460000276565552},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9269999861717224}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.630373477935791},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6253335475921631},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.6092826128005981},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5049193501472473},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4962931275367737},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4908474087715149},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.47768908739089966},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4630994498729706},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.4620946943759918},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4618455767631531},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35925614833831787},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3157007396221161},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2809649705886841},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23654431104660034},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07852736115455627},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016130","descriptor_name":"Immunophenotyping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018655","descriptor_name":"Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":10,"locations":[{"id":"doi:10.1158/1078-0432.ccr-18-2243","doi":"https://doi.org/10.1158/1078-0432.ccr-18-2243","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-18-2243","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmh:oai:cris.maastrichtuniversity.nl:openaire/1d1781d5-1416-4c66-963f-8f8bb65f2da6","doi":null,"is_oa":true,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/1d1781d5-1416-4c66-963f-8f8bb65f2da6","pdf_url":"https://pure.rug.nl/ws/files/1045639733/2219.pdf","source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"de Goeje, P L, Poncin, M, Bezemer, K, Kaijen-Lambers, M E H, Groen, H J M, Smit, E F, Dingemans, A-M C, Kunert, A, Hendriks, R W & Aerts, J G J V 2019, 'Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non-small Cell Lung Cancer Patients', Clinical Cancer Research, vol. 25, no. 7, pp. 2219-2227. https://doi.org/10.1158/1078-0432.CCR-18-2243","raw_type":"info:eu-repo/semantics/article"},{"id":"pmid:30642911","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30642911","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/36aa01a1-b0b2-4d6f-ac7c-957e6494b05e","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/36aa01a1-b0b2-4d6f-ac7c-957e6494b05e","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"de Goeje, P L, Poncin, M, Bezemer, K, Kaijen-Lambers, M E H, Groen, H J M, Smit, E F, Dingemans, A-M C, Kunert, A, Hendriks, R W & Aerts, J G J V 2019, 'Induction of peripheral effector CD8 T-cell proliferation by combination of paclitaxel, carboplatin, and bevacizumab in non\u2013small cell lung cancer patients', Clinical cancer research, vol. 25, no. 7, pp. 2219-2227. https://doi.org/10.1158/1078-0432.CCR-18-2243","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/81fafa7a-0c56-40bd-a910-57541963ad9a","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/81fafa7a-0c56-40bd-a910-57541963ad9a","pdf_url":null,"source":{"id":"https://openalex.org/S7407055350","display_name":"Amsterdam UMC (VU Amsterdam) - Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"de Goeje, P L, Poncin, M, Bezemer, K, Kaijen-Lambers, M E H, Groen, H J M, Smit, E F, Dingemans, A-M C, Kunert, A, Hendriks, R W & Aerts, J G J V 2019, 'Induction of peripheral effector CD8 T-cell proliferation by combination of paclitaxel, carboplatin, and bevacizumab in non\u2013small cell lung cancer patients', Clinical Cancer Research, vol. 25, no. 7, pp. 2219-2227. https://doi.org/10.1158/1078-0432.CCR-18-2243","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/3c13ac07-f7cc-49a8-99a2-aad3666a724e","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/3c13ac07-f7cc-49a8-99a2-aad3666a724e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"de Goeje, P L, Poncin, M, Bezemer, K, Kaijen-Lambers, M E H, Groen, H J M, Smit, E F, Dingemans, A M C, Kunert, A, Hendriks, R W & Aerts, J G J V 2019, 'Induction of peripheral effector CD8 T-cell proliferation by combination of paclitaxel, carboplatin, and bevacizumab in non\u2013small cell lung cancer patients', Clinical Cancer Research, vol. 25, no. 7, pp. 2219-2227. https://doi.org/10.1158/1078-0432.CCR-18-2243","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.rug.nl:openaire/8a019e99-54dd-4c8f-b15f-46e11cd598c3","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/8a019e99-54dd-4c8f-b15f-46e11cd598c3","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"de Goeje, P L, Poncin, M, Bezemer, K, Kaijen-Lambers, M E H, Groen, H J M, Smit, E F, Dingemans, A M C, Kunert, A, Hendriks, R W & Aerts, J G J V 2019, 'Induction of peripheral effector CD8 T-cell proliferation by combination of paclitaxel, carboplatin, and bevacizumab in non\u2013small cell lung cancer patients', Clinical Cancer Research, vol. 25, no. 7, pp. 2219-2227. https://doi.org/10.1158/1078-0432.CCR-18-2243","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/3c13ac07-f7cc-49a8-99a2-aad3666a724e","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/3c13ac07-f7cc-49a8-99a2-aad3666a724e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research, 25(7), 2219 - 2227. American Association for Cancer Research Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:um:oai:cris.maastrichtuniversity.nl:publications/1d1781d5-1416-4c66-963f-8f8bb65f2da6","doi":null,"is_oa":false,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/1d1781d5-1416-4c66-963f-8f8bb65f2da6","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research, 25(7), 2219 - 2227. American Association for Cancer Research Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/81fafa7a-0c56-40bd-a910-57541963ad9a","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/81fafa7a-0c56-40bd-a910-57541963ad9a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research, 25(7), 2219 - 2227. American Association for Cancer Research Inc.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:cris.maastrichtuniversity.nl:openaire/1d1781d5-1416-4c66-963f-8f8bb65f2da6","doi":null,"is_oa":true,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/1d1781d5-1416-4c66-963f-8f8bb65f2da6","pdf_url":"https://pure.rug.nl/ws/files/1045639733/2219.pdf","source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"de Goeje, P L, Poncin, M, Bezemer, K, Kaijen-Lambers, M E H, Groen, H J M, Smit, E F, Dingemans, A-M C, Kunert, A, Hendriks, R W & Aerts, J G J V 2019, 'Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non-small Cell Lung Cancer Patients', Clinical Cancer Research, vol. 25, no. 7, pp. 2219-2227. https://doi.org/10.1158/1078-0432.CCR-18-2243","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2492487125","display_name":null,"funder_award_id":"UM 2010-4883","funder_id":"https://openalex.org/F4320322777","funder_display_name":"KWF Kankerbestrijding"}],"funders":[{"id":"https://openalex.org/F4320307779","display_name":"Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320322777","display_name":"KWF Kankerbestrijding","ror":"https://ror.org/0368jnd28"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2910094802.pdf","grobid_xml":"https://content.openalex.org/works/W2910094802.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1519460121","https://openalex.org/W1757407923","https://openalex.org/W1767508090","https://openalex.org/W1983517349","https://openalex.org/W2017364703","https://openalex.org/W2037342985","https://openalex.org/W2046094997","https://openalex.org/W2056893124","https://openalex.org/W2106539209","https://openalex.org/W2145174070","https://openalex.org/W2198093519","https://openalex.org/W2210453860","https://openalex.org/W2282550179","https://openalex.org/W2301488980","https://openalex.org/W2527905628","https://openalex.org/W2528647848","https://openalex.org/W2529904548","https://openalex.org/W2576658154","https://openalex.org/W2578528809","https://openalex.org/W2594793697","https://openalex.org/W2605630275","https://openalex.org/W2609289346","https://openalex.org/W2745683917","https://openalex.org/W2753065806","https://openalex.org/W2805354595"],"related_works":["https://openalex.org/W2936944502","https://openalex.org/W2992927759","https://openalex.org/W2357494848","https://openalex.org/W2501800173","https://openalex.org/W2589025500","https://openalex.org/W2569330503","https://openalex.org/W2949162809","https://openalex.org/W1986696263","https://openalex.org/W2767678023","https://openalex.org/W4408989291"],"abstract_inverted_index":{"PURPOSE:":[0],"Chemotherapy":[1],"has":[2],"long":[3],"been":[4],"the":[5,39,50,58,63,84,102,128,212],"standard":[6],"treatment":[7,106],"for":[8,22,221],"advanced":[9],"stage":[10,79],"non-small":[11],"cell":[12],"lung":[13,228],"cancer":[14],"(NSCLC),":[15],"but":[16],"checkpoint":[17,66,200,225],"inhibitors":[18,67],"are":[19],"now":[20],"approved":[21],"use":[23],"in":[24,68,83,211,227],"several":[25,122],"patient":[26],"groups":[27],"and":[28,100,104,114,127,132,155],"combinations.":[29],"To":[30],"design":[31],"optimal":[32],"combination":[33],"strategies,":[34],"a":[35,219],"better":[36],"understanding":[37],"of":[38,42,53,75,109,124,130,190,195,203],"immune-modulatory":[40,51],"capacities":[41],"conventional":[43],"treatments":[44],"is":[45],"needed.":[46],"Therefore,":[47],"we":[48],"investigated":[49],"effects":[52],"paclitaxel/carboplatin/bevacizumab":[54],"(PCB),":[55],"focusing":[56],"on":[57,135],"immune":[59],"populations":[60],"associated":[61],"with":[62,78,89,161,224],"response":[64],"to":[65,208],"peripheral":[69],"blood.":[70],"EXPERIMENTAL":[71],"DESIGN:":[72],"A":[73],"total":[74],"223":[76],"patients":[77],"IV":[80],"NSCLC,":[81],"enrolled":[82],"NVALT12":[85],"study,":[86],"received":[87],"PCB,":[88],"or":[90,182],"without":[91],"nitroglycerin":[92],"patch.":[93],"Peripheral":[94],"blood":[95],"was":[96,205],"collected":[97],"at":[98],"baseline":[99],"after":[101,173],"first":[103],"second":[105],"cycle,":[107],"proportions":[108],"T":[110,125,146,164,192],"cells,":[111,113,193],"B":[112],"monocytes":[115],"were":[116,138],"determined":[117],"by":[118],"flow":[119],"cytometry.":[120],"Furthermore,":[121],"subsets":[123,137],"cells":[126,147,197],"expression":[129],"Ki67":[131],"coinhibitory":[133,199],"receptors":[134],"these":[136],"determined.":[139],"RESULTS:":[140],"effector":[141,196],"subsets.":[142],"The":[143],"proliferating":[144],"CD8":[145,163,191],"more":[148],"highly":[149],"expressed":[150],"programmed":[151],"death":[152],"receptor":[153],"(PD)-1":[154],"cytotoxic":[156],"T-lymphocyte-associated":[157],"antigen-4":[158],"(CTLA-4)":[159],"compared":[160],"nonproliferating":[162],"cells.":[165],"Immunologic":[166],"responders":[167],"(iR;":[168],">2":[169],"fold":[170],"increased":[171],"proliferation":[172,189,204],"treatment)":[174],"did":[175],"not":[176,206],"show":[177],"an":[178],"improved":[179],"progression-free":[180],"(PFS)":[181],"overall":[183],"survival":[184],"(OS).":[185],"CONCLUSIONS:":[186],"Paclitaxel/carboplatin/bevacizumab":[187],"induces":[188],"consisting":[194],"expressing":[198],"molecules.":[201],"Induction":[202],"correlated":[207],"clinical":[209,214],"outcome":[210],"current":[213],"setting.":[215],"Our":[216],"findings":[217],"provide":[218],"rationale":[220],"combining":[222],"PCB":[223],"inhibition":[226],"cancer.":[229]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2910094802","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2019-01-25T00:00:00"}
